Paion AG - ESG Rating & Company Profile powered by AI
The report of Paion AG is assembled by All Street Sevva using cutting edge AI. This Sustainability score for Paion AG indicates the company's reporting of the United Nations Sustainable Development Goals. This assessment of Paion AG uses data points from across the internet and also from public filings by Paion AG.
Paion AG in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.3; made up of an environmental score of 8.0, social score of 8.0 and governance score of 6.0.
7.3
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 160 | YungShin Global Holding Corp | 7.5 | High |
| 160 | Zentiva SA | 7.5 | High |
| 191 | Paion AG | 7.3 | High |
| 191 | Cellectis SA | 7.3 | High |
| 191 | Aurinia Pharmaceuticals Inc | 7.3 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Paion AG have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Paion AG disclose current and historical energy intensity?
Sign up for free to unlockDoes Paion AG report the average age of the workforce?
Sign up for free to unlockDoes Paion AG reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Paion AG disclose its ethnicity pay gap?
Sign up for free to unlockDoes Paion AG disclose cybersecurity risks?
Sign up for free to unlockDoes Paion AG offer flexible work?
Sign up for free to unlockDoes Paion AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Paion AG disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Paion AG conduct supply chain audits?
Sign up for free to unlockDoes Paion AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Paion AG conduct 360 degree staff reviews?
Sign up for free to unlockDoes Paion AG disclose the individual responsible for D&I?
Sign up for free to unlockDoes Paion AG disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Paion AG disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Paion AG disclose water use targets?
Sign up for free to unlockDoes Paion AG have careers partnerships with academic institutions?
Sign up for free to unlockDid Paion AG have a product recall in the last two years?
Sign up for free to unlockDoes Paion AG disclose incidents of discrimination?
Sign up for free to unlockDoes Paion AG allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Paion AG issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Paion AG disclose parental leave metrics?
Sign up for free to unlockDoes Paion AG disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Paion AG disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Paion AG disclose the pay ratio of women to men?
Sign up for free to unlockDoes Paion AG support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Paion AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Paion AG reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Paion AG involved in embryonic stem cell research?
Sign up for free to unlockDoes Paion AG disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Paion AG disclose its waste policy?
Sign up for free to unlockDoes Paion AG report according to TCFD requirements?
Sign up for free to unlockDoes Paion AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Paion AG disclose energy use targets?
Sign up for free to unlockDoes Paion AG disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Paion AG have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Paion AG
These potential risks are based on the size, segment and geographies of the company.
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation. It is also developing Angiotensin II, a vasoconstrictor indicated for the treatment of refractory hypotension in adults with septic or other distributive shock; and Eravacycline, a novel fluorocycline antibiotic indicated for the treatment of complicated intra-abdominal infections in adults. The company has partnerships and license agreements with Cosmo Pharmaceuticals, Wuhan Humanwell Innovative Drug Research and Development Center Limited Company, Hana Pharm, Yichang Humanwell, and Mundipharma. Paion AG was founded in 2000 and is based in Aachen, Germany.